24 May 2013
Keywords: gsk, treximet, receives, fda, approval, uk, drug
Article | 21 April 2008
UK drug major GlaxoSmithKline and US company Pozen's co-developed long-awaited migraine drug, Treximet, has finally received US Food
and Drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 April 2008
28 April 2008
23 May 2013
© 2013 thepharmaletter.com